TRANSCRIPTA
Status timeline
- 25 May 2024Application filedNew Application Entered
- 9 Dec 2024Assigned to an examining attorneyAssigned To Examiner
- 10 Dec 2024Office action issuedNon-Final Action Written
- 20 Dec 2024Office action issuedNon-Final Action Written
- 20 Dec 2024Response to office action filedTeas Response To Office Action Received
- 2 Jan 2025Approved for publicationApproved For Pub - Principal Register
- 28 Jan 2025Published for oppositionPublished For Opposition
- 18 Mar 2025Registered on the Principal RegisterRegistered-Principal Register
All 30 USPTO events
| 2025-03-18 | Registered-Principal Register |
| 2025-03-18 | Notice Of Registration Confirmation Emailed |
| 2025-01-28 | Published For Opposition |
| 2025-01-28 | Official Gazette Publication Confirmation E-Mailed |
| 2025-01-22 | Notification Of Notice Of Publication E-Mailed |
| 2025-01-02 | Preliminary/Voluntary Amendment - Entered |
| 2025-01-02 | Approved For Pub - Principal Register |
| 2024-12-27 | Assigned To Lie |
| 2024-12-20 | Non-Final Action Written |
| 2024-12-20 | Non-Final Action E-Mailed |
| 2024-12-20 | Notification Of Non-Final Action E-Mailed |
| 2024-12-20 | Teas Response To Office Action Received |
| 2024-12-20 | Correspondence Received In Law Office |
| 2024-12-20 | Teas/Email Correspondence Entered |
| 2024-12-19 | Review Of Correspondence Complete - Information Made Of Record |
| 2024-12-19 | Attorney Review Completed |
| 2024-12-19 | Preliminary/Voluntary Amendment - Entered |
| 2024-12-19 | Preliminary/Voluntary Amendment - Entered |
| 2024-12-18 | Examiners Amendment -Written |
| 2024-12-18 | Examiners Amendment E-Mailed |
| 2024-12-18 | Notification Of Examiners Amendment E-Mailed |
| 2024-12-18 | Examiner's Amendment Entered |
| 2024-12-10 | Non-Final Action Written |
| 2024-12-10 | Non-Final Action E-Mailed |
| 2024-12-10 | Notification Of Non-Final Action E-Mailed |
| 2024-12-09 | Assigned To Examiner |
| 2024-12-03 | New Application Office Supplied Data Entered |
| 2024-11-07 | Teas Voluntary Amendment Received |
| 2024-11-07 | Teas Amendment Entered Before Attorney Assigned |
| 2024-05-25 | New Application Entered |
Goods & services
Class 42 Technology & SaaS
Scientific, biotechnology, and medical research and development services; medical testing services, namely, blood, cell and/or tissue sample preparation and testing; developing potential therapies and interventions in the field of rare diseases, namely, development of pharmaceutical compounds, cell- and gene therapies, antibodies, personalized medicine, drug repurposing; performing medical nonclinical and clinical research in the field of rare diseases
First use anywhere 0 Apr 2024 · First use in commerce 0 Apr 2024
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 18 Mar 2025; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.